Information  X 
Enter a valid email address

Lipoxen PLC (XEN)

  Print      Mail a friend

Friday 21 January, 2011

Lipoxen PLC

Director/PDMR Shareholding

RNS Number : 8984Z
Lipoxen PLC
21 January 2011
 



 

 

 

Lipoxen plc

 ("Lipoxen" or the "Company")

 

Director dealings

 

The Company was informed on 20 January 2011 that FDS Pharma Ass and Related Parties disposed of 925,000 ordinary shares of 0.5p each ("Ordinary Shares") over 16 separate trades at an average price of 11.23 pence between 16 November and 13 December 2010.

 

Following these disposals FDS Pharma Ass and Related Parties have an interest in Lipoxen of 41,440,059 Ordinary Shares representing 23.38 per cent of the issued Ordinary Share capital in the Company.

 

Enquires:

 

Lipoxen plc

+44 (0)20 7389 5015

M. Scott Maguire, Chief Executive Officer




Singer Capital Markets (nominated adviser)

+44 (0)20 3205 7500

Jeff Keating / Claes Spång




Walbrook PR Ltd

+44 (0)20 7933 8780

Bob Huxford (Media Enquiries)

Mob: 07747 653 908

bob.huxford@walbrookpr.com

 

Paul Cornelius (Investor Enquiries)

Mob: 07866 384 707

paul.cornelius@walbrookir.com



 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSMMGZMFMNGMZM